Navigation Links
Drug Eluting Nanostructured Coatings Enable Targeted Drug Therapy for Orthopedic Patients

Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents .

Nanotechnology promises yet another advance by delivering therapeutic agents at desired rates exactly where needed in the body.

In a paper presented at the NSTI Nanotech 2007 Conference, researchers at the University of California, San Francisco demonstrate how they have created nanotubes from biocompatible metal oxides that can hold therapeutic proteins or drugs and deliver these agents in a highly-controlled manner.

The fabrication strategies developed by the authors is flexible in terms of controlling the diameter and length scales of the tubes. By changing these physical parameters of nanotubes, they could precisely control the dosage and deliver drugs at physiological rates for desired duration of time.

In the case of orthopedic implants with nanotubes on the implant surfaces, drugs such as antibiotics can be loaded in the tubes and released right at the site of implantation. This method, which targets the drug where it is needed, can avoid the side effects due to high dosages normally given to patients. Further, in cases where a very long treatment regimen is needed, such as in growth factor therapy, nanotubes may provide superior performance.

According to Ketul C. Popat, "When a person has an orthopedic implant surgery, they normally will have to take antibiotics and growth factors either orally or by injection. There are several side effects associated with taking drugs this way which can be very painful for the patient.

However, by placing the drugs on to the surface of these implants, we can deliver them right where they are needed and can avoid larger doses and side effects. The nanostructured coating on the implant surface helps the drug to maintain its bioavailability as well as deliver the drugs at physiological rates for a desired duration of time."


'"/>




Page: 1

Related medicine news :

1. Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts
2. Poor Andhra Women Enable Bypass Surgery Paying 50 Paise Each
3. Small Biosensor To Enable Cancer Detection
4. New Technique Enables Better Nursing Of Robin Sequence Infants
5. Bad Enzymes Found To Enable Brain Recovery Following Stroke
6. Decision-Making Enabled By Neurons: Value Assigned To Available Choices.
7. Micro vascular Disease Enabled with a Superior Test, Courtesy: Women’s Heart Progra
8. Glucose Enables Speedy Recovery From Malaria
9. Single Sugar Enables Antibody to Treat Inflammation
10. Cochlear Implants in Both Ears Enables Better Hearing
11. Electronic Nerve Stimulator Enables Walking
Post Your Comments:
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...ociated with multiple positive social outcomes,// ...n the January 2nd edition of the Journal of Acquir...HIV care did not appear to lead to stigmatisation .... Although there was a non-significant increase in...
...instituted by the NHS trust to cater to mental pro...inding the Gap’, a document enabled by Durham Coun...d for a regular service for 16- to 18-year-olds, i...hrew light on the differences in treatment meted o...
...Center for Complementary //and Alternative Medicin...e urging consumers and physicians to communicate b... are trying out in order to ensure safe and integr... a survey conducted by NCCAM, by examining the tel...
...es detected annually in Thailand is an ongoing cha...ccording to Somchai Pinyopornpaitch, deputy direct...B cases have increased for several years despite h... in Thailand is currently 50 per 100,000 people, w...
Other Medicine News:Health News:HIV Home-based Care Produces Positive Outcomes in Uganda 2Health News:HIV Home-based Care Produces Positive Outcomes in Uganda 3Health News:Elderly Patients Usually Keep Mum About Use of Alternative Medicine , Reveals Survey 2
(Date:10/7/2008)...Newswire/ -- Prometheus Laboratories Inc., a,speci...ngs from its,development of PROMETHEUS(R) IBS Diag...e bowel syndrome (IBS). The findings suggest measu...biomarkers in blood samples,between IBS and non-IB...,combined with a proprietary algorithm, led to th...
(Date:10/7/2008)... /- The Texas Cardiac Arrhythmia,Inst...n selected as one of,only a few sites in the natio... for a new device to treat persistent atrial fibri...g and research center specializing in heart,rhythm...edical Center and,Texas Cardiovascular Consultants...
(Date:10/7/2008)... Acetate Prevented Immunologic Changes Induced by ...ease, Additional Data Indicates Potential in Treat...t. 7 /- Alba Therapeutics Corporation...week at the American,College of Gastroenterology (...dy CLIN 1001-004, the first Phase IIa trial conduc...
(Date:10/7/2008)...Oct. 7 /- A study published in the,sc...ell self-renewal,reported that InVitria,s ( http:...serum albumin) was an effective replacement to bov...e entitled, "The ground state of embryonic stem ce...Cellastim as a recombinant,albumin in place of ani...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Smart Balance Inc to Hold Annual Meeting of Stockholders on May 21 2008 17764 1Analysis shows combining sorafenib with carboplatin paclitaxel adds no benefit in lung cancer 17762 1Analysis shows combining sorafenib with carboplatin paclitaxel adds no benefit in lung cancer 17762 2Extreme nausea and vomiting varies among pregnant women from different countries 3058 1Extreme nausea and vomiting varies among pregnant women from different countries 3058 2FFF Enterprises Selects A10 Networks AX Series Advanced Traffic Manager 17758 1FFF Enterprises Selects A10 Networks AX Series Advanced Traffic Manager 17758 2FFF Enterprises Selects A10 Networks AX Series Advanced Traffic Manager 17758 3
...TERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2007 - Pa...chnology company,dedicated to developing the next ...y announced the results of a new study,indicating ... have,reduced potential for the development of res...in laboratory assays. The study,carried out by sc...
...ublished by the New England Journal of Medicine th...ONLY WHEN NEEDED AND THE DISEASE CAN BE CONTROLLED...drug useless for mild persistent,types affecting o...’s commitment to pneumological research , MI...daily dose,of cortisone necessary for the control ...
Other Medicine Technology:Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 2Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 3Mild Asthma, a Revolutionary Therapy from Italian Research 2Mild Asthma, a Revolutionary Therapy from Italian Research 3
The portable, cost-effective system designed for fast studies and bedside reporting. The size, features and cost make this a perfect unit for a new practice, or as a second or third unit for larger h
...re intended for the most demanding work, especiall...re ideal for tweezing out in grown hairs or fine m...s. These Dumont/Swiss watchmaker forceps are teflo...made from the highest quality stainless steel and ...
Vertigraft Humerus/Tibia Shaft an Cross-sections with even Anterior and Posterior heights may be processed from either the humerus or tibia. Anterior lumbar interbody fusion, corpectomy. Freeze-drie
...or column support for single or multilevel corpect...system consists of one or more Peek Carbon fiber p... accommodating various patient needs. The Peek Car... biomechanical properties of human cortical bone, ...
Medicine Products: